Venus Medtech (Hangzhou) Inc.

VMTHF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$741-$704-$858-$374
Dep. & Amort.$111$125$112$52
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$310-$117-$130-$151
Other Non-Cash$344$86$146$16
Operating Cash Flow$24-$610-$729-$457
Investing Activities
PP&E Inv.-$34-$261-$170-$125
Net Acquisitions-$0-$4-$813-$176
Inv. Purchases-$0-$45-$92-$420
Inv. Sales/Matur.$0$22$0$54
Other Inv. Act.$15-$60$3$14
Investing Cash Flow-$20-$347-$1,072-$653
Financing Activities
Debt Repay.-$423-$130$702-$20
Stock Issued$0$0$0$1,191
Stock Repurch.$0$0$0-$73
Dividends Paid$0$0$0$0
Other Fin. Act.-$64-$44-$67$293
Financing Cash Flow-$487-$174$635$1,391
Forex Effect$7$26$91-$34
Net Chg. in Cash-$476-$1,105-$1,076$247
Supplemental Information
Beg. Cash$774$1,879$2,955$2,708
End Cash$298$774$1,879$2,955
Free Cash Flow-$18-$873-$908-$602
Venus Medtech (Hangzhou) Inc. (VMTHF) Financial Statements & Key Stats | AlphaPilot